Medicamen Biotech Limited Cash Flow Conversion Efficiency

Latest as of September 2025: -0.045x

Medicamen Biotech Limited cash flow conversion efficiency. Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has a cash flow conversion efficiency ratio of -0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-124.06 Million ≈ $-1.34 Million USD) by net assets (Rs2.75 Billion ≈ $29.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Medicamen Biotech Limited (2006–2026)

Cash flow conversion efficiency of Medicamen Biotech Limited from 2006 to 2026. This chart illustrates how Medicamen Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MEDICAMEQ stock price for real-time trading data and today's change.

Medicamen Biotech Limited Cash Flow Conversion Ratio Explained

Medicamen Biotech Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Medicamen Biotech Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medicamen Biotech Limited ranked by their cash flow conversion efficiency. Also see MEDICAMEQ market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Rosebank Industries PLC LSE:ROSE	0.000x
MK Trend Co. Ltd. KO:069640	-0.361x
Cheil Grinding KO:001560	-0.006x
East Asia Holdings Investment Limited KQ:900110	0.017x
Augwind Energy Tech Storage Ltd TA:AUGN	-0.081x
Hung Chou Fiber Ind Co Ltd TW:1413	0.023x
FELIX Gold Ltd AU:FXG	-0.022x
LAVA THERAP. B.V. EO-12 F:4PKB	N/A

Annual Cash Flow Conversion Efficiency for Medicamen Biotech Limited (2006–2026)

The table below shows the annual cash flow conversion efficiency of Medicamen Biotech Limited from 2006 to 2026. Review MEDICAMEQ cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs2.76 Billion ≈ $29.80 Million	Rs-349.31 Million ≈ $-3.78 Million	-0.127x	-173.60%
2025-03-31	Rs2.13 Billion ≈ $23.01 Million	Rs-98.59 Million ≈ $-1.07 Million	-0.046x	-42.21%
2024-03-31	Rs2.07 Billion ≈ $22.38 Million	Rs-67.44 Million ≈ $-729.32K	-0.033x	-0.14%
2023-03-31	Rs1.93 Billion ≈ $20.92 Million	Rs-62.93 Million ≈ $-680.54K	-0.033x	-215.97%
2022-03-31	Rs1.46 Billion ≈ $15.84 Million	Rs41.09 Million ≈ $444.38K	0.028x	-70.81%
2021-03-31	Rs1.33 Billion ≈ $14.37 Million	Rs127.72 Million ≈ $1.38 Million	0.096x	-9.00%
2020-03-31	Rs1.21 Billion ≈ $13.11 Million	Rs128.02 Million ≈ $1.38 Million	0.106x	+112.74%
2019-03-31	Rs866.34 Million ≈ $9.37 Million	Rs43.01 Million ≈ $465.12K	0.050x	+167.91%
2018-03-31	Rs746.08 Million ≈ $8.07 Million	Rs-54.54 Million ≈ $-589.80K	-0.073x	-154.50%
2017-03-31	Rs267.81 Million ≈ $2.90 Million	Rs35.92 Million ≈ $388.49K	0.134x	-61.29%
2016-03-31	Rs179.09 Million ≈ $1.94 Million	Rs62.06 Million ≈ $671.13K	0.347x	+281.86%
2015-03-31	Rs171.85 Million ≈ $1.86 Million	Rs-32.74 Million ≈ $-354.11K	-0.191x	-161.32%
2014-03-31	Rs165.38 Million ≈ $1.79 Million	Rs51.39 Million ≈ $555.74K	0.311x	+410.42%
2013-03-31	Rs157.17 Million ≈ $1.70 Million	Rs-15.73 Million ≈ $-170.14K	-0.100x	+42.34%
2012-03-31	Rs201.01 Million ≈ $2.17 Million	Rs-34.90 Million ≈ $-377.38K	-0.174x	-131.21%
2011-03-31	Rs204.12 Million ≈ $2.21 Million	Rs113.52 Million ≈ $1.23 Million	0.556x	+722.44%
2010-03-31	Rs162.61 Million ≈ $1.76 Million	Rs11.00 Million ≈ $118.92K	0.068x	-89.45%
2009-03-31	Rs129.60 Million ≈ $1.40 Million	Rs83.07 Million ≈ $898.33K	0.641x	+227.09%
2008-03-31	Rs115.83 Million ≈ $1.25 Million	Rs22.70 Million ≈ $245.46K	0.196x	+662.67%
2007-03-31	Rs100.73 Million ≈ $1.09 Million	Rs2.59 Million ≈ $27.99K	0.026x	-91.54%
2006-03-31	Rs85.67 Million ≈ $926.49K	Rs26.02 Million ≈ $281.45K	0.304x	--

About Medicamen Biotech Limited

NSE:MEDICAMEQ India Drug Manufacturers - Specialty & Generic

Market Cap

$38.60 Million

Rs3.57 Billion INR

Market Cap Rank

#22646 Global

#1250 in India

Share Price

Rs263.15

Change (1 day)

+0.38%

52-Week Range

Rs219.88 - Rs415.95

All Time High

Rs1195.88